Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1515445 | 0.74 | SMN1; SMN2 (0.48) | HRH1MAP4K4SMN1; SMN2MAPTLIN28A | |
| SCHEMBL30418424 | 0.73 | HRH1 (0.42) | HRH1SMN1; SMN2MAPTLIN28ATDP1 | |
| SCHEMBL17618302 | 0.72 | KMT2A (0.48) | HRH1SIGMAR1KDM4E | |
| SCHEMBL1515203 | 0.71 | HPGD (0.49) | HRH1SMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL11541050 | 0.70 | CYP19A1 (0.40) | CYP19A1HRH1SMN1; SMN2MAPTLIN28A | |
| SCHEMBL11541056 | 0.70 | CYP19A1 (0.40) | CYP19A1HRH1SMN1; SMN2MAPTLIN28A | |
| SCHEMBL11541062 | 0.70 | CYP19A1 (0.40) | CYP19A1HRH1SMN1; SMN2MAPTLIN28A | |
| SCHEMBL8911524 | 0.69 | HPGD (0.55) | HRH1SMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL10217436 | 0.69 | SLC6A4 (0.43) | HRH1SMN1; SMN2MAPTLIN28ATDP1 | |
| Bromide SCHEMBL28182316 | 0.68 | HPGD (0.54) | HRH1SMN1; SMN2NPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160083558-A1 | OXYGEN SCAVENGERS, COMPOSITIONS COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | PLASTIPAK PACKAGING, INC. (US) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083558-A1 | OXYGEN SCAVENGERS, COMPOSITIONS COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | PRDX5, LPO, CAT | CYP19A1 1356/4885HRH1 4866/4885MAP4K4 4738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.